Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 0.75
ICAD's Cash to Debt is ranked lower than
56% of the 1618 Companies
in the Global Software - Application industry.

( Industry Median: 25.64 vs. ICAD: 0.75 )
ICAD' s 10-Year Cash to Debt Range
Min: 0.04   Max: No Debt
Current: 0.75

Equity to Asset 0.36
ICAD's Equity to Asset is ranked lower than
56% of the 1589 Companies
in the Global Software - Application industry.

( Industry Median: 0.60 vs. ICAD: 0.36 )
ICAD' s 10-Year Equity to Asset Range
Min: 0.32   Max: 0.91
Current: 0.36

0.32
0.91
F-Score: 4
Z-Score: -2.08
M-Score: -2.36
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -5.37
ICAD's Operating margin (%) is ranked lower than
53% of the 1604 Companies
in the Global Software - Application industry.

( Industry Median: 5.48 vs. ICAD: -5.37 )
ICAD' s 10-Year Operating margin (%) Range
Min: -187.4   Max: 12.71
Current: -5.37

-187.4
12.71
Net-margin (%) -23.01
ICAD's Net-margin (%) is ranked lower than
59% of the 1602 Companies
in the Global Software - Application industry.

( Industry Median: 3.67 vs. ICAD: -23.01 )
ICAD' s 10-Year Net-margin (%) Range
Min: -188.36   Max: 11.62
Current: -23.01

-188.36
11.62
ROE (%) -35.59
ICAD's ROE (%) is ranked lower than
61% of the 1564 Companies
in the Global Software - Application industry.

( Industry Median: 6.77 vs. ICAD: -35.59 )
ICAD' s 10-Year ROE (%) Range
Min: -148.78   Max: 6.62
Current: -35.59

-148.78
6.62
ROA (%) -12.91
ICAD's ROA (%) is ranked lower than
58% of the 1616 Companies
in the Global Software - Application industry.

( Industry Median: 3.63 vs. ICAD: -12.91 )
ICAD' s 10-Year ROA (%) Range
Min: -72.62   Max: 5.95
Current: -12.91

-72.62
5.95
ROC (Joel Greenblatt) (%) -106.28
ICAD's ROC (Joel Greenblatt) (%) is ranked lower than
58% of the 1600 Companies
in the Global Software - Application industry.

( Industry Median: 30.96 vs. ICAD: -106.28 )
ICAD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -3219.93   Max: 222.81
Current: -106.28

-3219.93
222.81
Revenue Growth (%) 4.40
ICAD's Revenue Growth (%) is ranked higher than
66% of the 1208 Companies
in the Global Software - Application industry.

( Industry Median: 6.30 vs. ICAD: 4.40 )
ICAD' s 10-Year Revenue Growth (%) Range
Min: -41.4   Max: 31.4
Current: 4.4

-41.4
31.4
EBITDA Growth (%) -31.60
ICAD's EBITDA Growth (%) is ranked lower than
54% of the 951 Companies
in the Global Software - Application industry.

( Industry Median: 7.70 vs. ICAD: -31.60 )
ICAD' s 10-Year EBITDA Growth (%) Range
Min: -75.1   Max: 207.2
Current: -31.6

-75.1
207.2
EPS Growth (%) 1.00
ICAD's EPS Growth (%) is ranked higher than
64% of the 892 Companies
in the Global Software - Application industry.

( Industry Median: 8.80 vs. ICAD: 1.00 )
ICAD' s 10-Year EPS Growth (%) Range
Min: -47.9   Max: 58.1
Current: 1

-47.9
58.1
» ICAD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

ICAD Guru Trades in Q1 2013

Jim Simons 253,860 sh (+21.55%)
Lee Ainslie Sold Out
» More
Q2 2013

ICAD Guru Trades in Q2 2013

Jim Simons 259,860 sh (+2.36%)
» More
Q3 2013

ICAD Guru Trades in Q3 2013

Jim Simons 272,160 sh (+4.73%)
» More
Q4 2013

ICAD Guru Trades in Q4 2013

Jim Simons 347,060 sh (+27.52%)
» More
» Details

Insider Trades

Latest Guru Trades with ICAD

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Lee Ainslie 2013-03-31 Sold Out $4.42 - $6.64 $ 8.5162%0
Lee Ainslie 2012-12-31 New Buy$1.91 - $4.8 $ 8.51175%6791
Lee Ainslie 2012-09-30 Sold Out 0.0012%$1.9 - $2.89 $ 8.51283%0
Lee Ainslie 2012-03-31 Reduce -24.08%$2.35 - $3.4 $ 8.51227%184141
Lee Ainslie 2011-03-31 New Buy$5.2 - $7.4 $ 8.5132%242552
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 4.30
ICAD's P/B is ranked lower than
57% of the 1504 Companies
in the Global Software - Application industry.

( Industry Median: 2.45 vs. ICAD: 4.30 )
ICAD' s 10-Year P/B Range
Min: 0.43   Max: 9.48
Current: 4.3

0.43
9.48
P/S 2.79
ICAD's P/S is ranked lower than
56% of the 1650 Companies
in the Global Software - Application industry.

( Industry Median: 1.98 vs. ICAD: 2.79 )
ICAD' s 10-Year P/S Range
Min: 0.76   Max: 24.26
Current: 2.79

0.76
24.26
EV-to-EBIT 500.00
ICAD's EV-to-EBIT is ranked lower than
81% of the 1278 Companies
in the Global Software - Application industry.

( Industry Median: 17.39 vs. ICAD: 500.00 )
ICAD' s 10-Year EV-to-EBIT Range
Min: 5.8   Max: 897.3
Current: 500

5.8
897.3

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 10.80
ICAD's Price/DCF (Projected) is ranked lower than
80% of the 753 Companies
in the Global Software - Application industry.

( Industry Median: 1.50 vs. ICAD: 10.80 )
ICAD' s 10-Year Price/DCF (Projected) Range
Min: 0.95   Max: 14.76
Current: 10.8

0.95
14.76
Price/Median PS Value 0.90
ICAD's Price/Median PS Value is ranked higher than
74% of the 1516 Companies
in the Global Software - Application industry.

( Industry Median: 1.10 vs. ICAD: 0.90 )
ICAD' s 10-Year Price/Median PS Value Range
Min: 0.35   Max: 7.08
Current: 0.9

0.35
7.08
Earnings Yield (Greenblatt) 0.20
ICAD's Earnings Yield (Greenblatt) is ranked lower than
74% of the 1324 Companies
in the Global Software - Application industry.

( Industry Median: 5.40 vs. ICAD: 0.20 )
ICAD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 17.2
Current: 0.2

0.1
17.2
Forward Rate of Return (Yacktman) -0.06
ICAD's Forward Rate of Return (Yacktman) is ranked higher than
61% of the 1007 Companies
in the Global Software - Application industry.

( Industry Median: 5.32 vs. ICAD: -0.06 )
ICAD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -11.1   Max: -2.5
Current: -0.06

-11.1
-2.5

Business Description

Industry: Application Software » Software - Application
Compare:CRM, SQI, RHT, INTU, ADBE » details
Traded in other countries:HWT1.Germany
Icad Inc., is incorporated in Delaware corp. The Company is a provider of advanced image analysis and workflow solutions that enable radiologists and other healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. It high-performance, expandable Computer-Aided Detection (CAD) systems and workflow solutions for mammography, such as film-based, digital radiography (DR), in addition to computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). It offers a comprehensive range of high-performance upgradeable products for use with mammography, including digital radiography, computed radiography and film-based mammography. These solutions enable radiologists to better serve patients by identifying pathologies and pinpointing cancers. The company's solutions aid in the early detection of the prevalent cancers including breast, prostate and colon cancer. Early detection of cancer is the key to better prognosis, less invasive and lower treatment costs, and higher survival rates. The company's products are manufactured and assembled for it by a contract manufacturer of medical devices. Its manufacturing efforts are generally limited to purchasing and supply chain management, planning/scheduling, manufacturing engineering, service repairs, quality assurance, inventory management, and warehousing. Its products are sold through its direct regional sales organization in the U.S. as well as through its OEM partners, including GE Healthcare, Fuji Medical Systems, Siemens Medical, Philips Healthcare, Agfa Corporation, Sectra Medical Systems, Planmed, Fuji Medical Systems, IMS Giotto, and Carestream. The Company currently faces direct competition in its CAD business from Hologic, Inc. and imaging equipment manufacturers such as GE Healthcare, Siemens Medical, and Philips Medical Systems. The Company's systems are medical devices subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act with potentially significant costs for compliance.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide